HOME >> BIOLOGY >> NEWS
Clinical judgement still counts strongly alongside genetic testing

Suggestions that genetic tests are taken more into account than a doctor's clinical judgement are dismissed in new research sponsored by the ESRC and published as part of Social Science week.

And clinicians do not adopt a 'blunderbuss' or 'grape-shot' approach. Appropriate tests are ordered in the light of clinical decisions and differing diagnoses, according to the study led by Dr Joanna Latimer, of the School of Social Science, Cardiff University.

The findings are the result of a one-year, intensive case-study of dysmorphology - a specialty in clinical genetics which involves spotting disorders affecting physical development, before or after birth.

It includes recognising particular patterns of physical features in patients with a range of problems or 'troubles', sometimes including delayed intellectual development.

Patients are mainly babies, children and teenagers or young adults, and genetic services are involved because the majority of these syndromes have a genetic basis.

Dr Latimer said: "While there are an increasing number of laboratory examinations that can be made to investigate possible dysmorphic conditions - including DNA and chromosome testing - it is not the case that these are supplanting clinical expertise. Laboratory tests do not simply outweigh clinical evidence."

She continued: "The relationship between how the patient's condition reveals itself and the underlying DNA or chromosome evidence is not entirely predictable.

"Many syndromes are rare and complex, and the laboratory-based technology is not yet available with which to make their genetic basis visible. What we have found is that other, clinic-based techniques and technologies, such as photographs and family trees, have developed with which to do genetic profiling, and which help in distinguishing genetic conditions from other kinds of problems."
'"/>

Contact: Becky Gammon
becky.gammon@esrc.ac.uk
44-179-341-3122
Economic & Social Research Council
23-Jun-2004


Page: 1 2

Related biology news :

1. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
2. Jay Levy honored with 2004 Abbott Laboratories Award in Clinical and Diagnostic Immunology
3. Melvin Weinstein wins 2004 BD Award for Research in Clinical Microbiology
4. DFG to establish seven new Clinical Research Units
5. Clinical trial patients dont care about study sponsors or physician conflicts of interest
6. NIH establishes Rare Diseases Clinical Research Network
7. Clinical study reports findings of combination therapy with DOXIL
8. Clinical study results published in NEJM show promising data on Antegren (natalizumab)
9. Clinical trial shows timing of chemotherapy improves survival in breast cancer
10. Clinical services must catch up
11. Clinical Advances towards the simplification if HIV therapy: First once-daily dosing results for the HIV protease inhibitor, Agenerase

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently announced its newly ... health agencies of all sizes. With a focus on tracking symptoms and monitoring ... health care, Mosio helps public health departments automate communications and provide more personalized ...
(Date:7/31/2020)... (PRWEB) , ... July 30, 2020 , ... ... Research (SBIR) Phase II contract awarded by the Joint Science & Technology Office—Chemical ... this project is to develop, optimize, and scale-up a highly efficient mammalian cell ...
(Date:7/10/2020)... ... July 08, 2020 , ... ... and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 • 1:30 ... study, but what is the most effective way to complete one? Will the ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... Ohio (PRWEB) , ... July 16, 2020 , ... ... data solutions to aid in the early detection and prevention of high-burden diseases, ... to enable US-based hospitals and healthcare organizations to utilize existing data in order ...
(Date:7/10/2020)... KONG (PRWEB) , ... July 09, 2020 , ... ... compound called 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in zebrafish ... the PolyU research team led by Dr MA has been using the zebrafish ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... of 40% in 2020, despite many obstacles created as a result of COVID-19. ... revenue for its partnered medical practices and medical manufacturers by expanding access to ...
(Date:6/28/2020)... ... June 25, 2020 , ... With the COVID-19 ... or drug treatment. In an effort to better understand the cellular responses to ... largest imaging dataset portraying therapeutic compound effects from over 1,600 approved and referenced ...
Breaking Biology Technology:
Cached News: